Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
M	O
Service:	O
UROLOGY	O
Allergies:	O
No	O
Known	O
Allergies	O
/	O
Adverse	O
Drug	O
Reactions	O
Attending:	O
___.	O
Chief	O
Complaint:	O
prostate	O
cancer,	O
bladder	O
outlet	O
obstruction	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
cystoscopy,	O
transurethral	O
resection	O
of	O
prostate	O
(monopolar),	O
Dr.	O
___,	O
___	O
History	O
of	O
Present	O
Illness:	O
___	O
h/o	O
CaP	O
s/p	O
brachy	O
c/b	O
retention	O
Past	O
Medical	O
History:	O
PMH:	O
EF	O
51%,	O
HLD,	O
HTN,	O
OSA,	O
arthritis,	O
gout,	O
DMII	O
(diet	O
controlled),	O
CRI	O
(cr	O
1.3)	O
Social	O
History:	O
___	O
Family	O
History:	O
nc	O
Physical	O
Exam:	O
AVSS	O
NAD	O
no	O
resp	O
distress	O
abd	O
soft	O
nontender	O
nondistended	O
Pertinent	O
Results:	O
___	O
04:05PM	O
GLUCOSE-96	O
UREA	O
N-22*	O
CREAT-1.3*	O
SODIUM-142	O
POTASSIUM-4.3	O
CHLORIDE-103	O
TOTAL	O
CO2-32	O
ANION	O
GAP-11	O
___	O
04:05PM	O
estGFR-Using	O
this	O
___	O
04:05PM	O
CALCIUM-9.3	O
PHOSPHATE-3.6	O
MAGNESIUM-2.0	O
___	O
04:05PM	O
WBC-6.9	O
RBC-4.15*	O
HGB-11.4*	O
HCT-34.4*	O
MCV-83	O
MCH-27.5	O
MCHC-33.1	O
RDW-13.8	O
___	O
04:05PM	O
PLT	O
COUNT-124*	O
Brief	O
Hospital	O
Course:	O
The	O
patient	O
was	O
admitted	O
to	O
Dr.	O
___	O
service	O
after	O
TURP.	O
No	O
concerning	O
intraoperative	O
events	O
occurred;	O
please	O
see	O
dictated	O
operative	O
note	O
for	O
details.	O
The	O
patient	O
received	O
___	O
antibiotic	O
prophylaxis.	O
Patient's	O
postoperative	O
course	O
was	O
uncomplicated.	O
He	O
received	O
intravenous	O
antibiotics,	O
maintained	O
on	O
bedrest	O
and	O
continous	O
bladder	O
irrigation	O
overnight.	O
On	O
POD1,	O
the	O
CBI	O
and	O
foley	O
catheter	O
were	O
discontinued,	O
and	O
he	O
passed	O
a	O
voiding	O
trial.	O
His	O
urine	O
was	O
clear	O
yellow	O
without	O
clots	O
with	O
post-void	O
residual	O
less	O
than	O
voided	O
volumes.	O
He	O
remained	O
afebrile	O
throughout	O
his	O
hospital	O
stay.	O
At	O
discharge,	O
patient's	O
pain	O
well	O
controlled	O
with	O
oral	O
pain	O
medications,	O
tolerating	O
regular	O
diet,	O
ambulating	B-Independently_mobile
without	B-Independently_mobile
assistance,	B-Independently_mobile
and	O
voiding	O
without	O
difficulty.	O
He	O
was	O
given	O
oral	O
pain	O
medications	O
on	O
discharge,	O
without	O
antibiotics.	O
He	O
was	O
given	O
explicit	O
instructions	O
to	O
call	O
Dr.	O
___	O
follow-up.	O
Medications	O
on	O
Admission:	O
Meds:	O
ASA	O
(hasnt	O
taken	O
since	O
___,	O
atenolol,	O
lisinopril,	O
simvastatin,	O
levitra	O
Discharge	O
Medications:	O
1.	O
oxycodone	O
5	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
Q6H	O
(every	O
6	O
hours)	O
as	O
needed	O
for	O
pain.	O
Disp:*20	O
Tablet(s)*	O
Refills:*0*	O
2.	O
atenolol	O
50	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
3.	O
chlorthalidone	O
25	O
mg	O
Tablet	O
Sig:	O
0.5	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
4.	O
lisinopril	O
20	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
5.	O
simvastatin	O
40	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
6.	O
tamsulosin	O
0.4	O
mg	O
Capsule,	O
Ext	O
Release	O
24	O
hr	O
Sig:	O
Two	O
(2)	O
Capsule,	O
Ext	O
Release	O
24	O
hr	O
PO	O
HS	O
(at	O
bedtime).	O
1.	O
oxycodone	O
5	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
Q6H	O
(every	O
6	O
hours)	O
as	O
needed	O
for	O
pain.	O
Disp:*20	O
Tablet(s)*	O
Refills:*0*	O
2.	O
atenolol	O
50	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
3.	O
chlorthalidone	O
25	O
mg	O
Tablet	O
Sig:	O
0.5	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
4.	O
lisinopril	O
20	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
5.	O
simvastatin	O
40	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
6.	O
tamsulosin	O
0.4	O
mg	O
Capsule,	O
Ext	O
Release	O
24	O
hr	O
Sig:	O
Two	O
(2)	O
Capsule,	O
Ext	O
Release	O
24	O
hr	O
PO	O
HS	O
(at	O
bedtime).	O
Discharge	O
Disposition:	O
Home	O
Discharge	O
Diagnosis:	O
prostate	O
cancer,	O
bladder	O
outlet	O
obstruction	O
Discharge	O
Condition:	O
stable,	O
oriented,	B-Delirium
ambulating	O
Discharge	O
Instructions:	O
-No	O
vigorous	O
physical	O
activity	O
for	O
2	O
weeks.	O
-Expect	O
to	O
see	O
occasional	O
blood	O
in	O
your	O
urine	O
and	O
to	O
experience	O
urgency	O
and	O
frequecy	O
over	O
the	O
next	O
month.	O
-Tylenol	O
should	O
be	O
your	O
first	O
line	O
pain	O
medication,	O
a	O
narcotic	O
pain	O
medication	O
has	O
been	O
prescribed	O
for	O
breakthough	O
pain	O
>4.	O
Replace	O
Tylenol	O
with	O
narcotic	O
pain	O
medication.	O
Max	O
daily	O
Tylenol	O
dose	O
is	O
4gm,	O
note	O
that	O
narcotic	O
pain	O
medication	O
also	O
contains	O
Tylenol	O
(acetaminophen)	O
-Do	O
not	O
drive	O
or	O
drink	O
alcohol	O
while	O
taking	O
narcotics	O
-Colace	O
has	O
been	O
prescribed	O
to	O
avoid	O
post	O
surgical	O
constipation	B-Constipation
and	O
constipation	B-Constipation
related	O
to	O
narcotic	O
pain	O
medication,	O
discontinue	O
if	O
loose	O
stool	O
or	O
diarrhea	O
develops.	O
Followup	O
Instructions:	O
___	O

